12^th World Drug Delivery Summit September 24-26, 2018 Chicago, USA

Track 1: Drug Delivery Technology

Drug Delivery Conferences attains greater global significance as Drug Delivery plays an indispensable role in the future of the pharmaceutical research Novel drug delivery system is a mechanism by which a drug is delivered in such a way that it can reach the maximum level of efficacy. The conference includes topics like Lipid Polymers to enhance drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and methodical release of both hydrophilic and hydrophobic drugs. In vitro and in vivo dissolution testing is required to ensure that the drug dissolves at a steady and consistent rate in batch to batch of formulated drug product. The dissolution rate of poorly soluble drugs can be increased by dissolving them in liquid hydrophilic vehicles followed by soaking on highly porous materials. The major objective is to deliver an innovative speech on the latest Targeted drug delivery method for providing medication to a patient in a manner which increases the concentration of the medication in some parts of the body relative to others. Pharmacokinetic behavior in drug design and drug development for safety issues arise either as a result of animal toxicity testing or in the clinical program itself

12^th World Drug Delivery Summit, September 24-25, 2018 |Chicago, USA; 16^th Global Summit on Toxicology and Applied Pharmacology, October 15-16, 2018| Las Vegas, USA; 13^th International Conference on Biologics and Biosimilars, October 24-25, 2018| Boston, USA; 13^th International Conference on Biopharma and Biotherapeutics, October 24-25, 2018| Boston,  USA;

Track 2: Novel Drug Delivery Systems

For the target of amplifying knowledge on the current researchers on developing drug delivery systems via novel techniques for Pharmaceutical formulation development, Drug Delivery conference is centred around quality topics including Liposomes, Dendrimer, Targeted Drug Delivery design, versatile polymer in Drug Delivery and Controlled Drug Delivery, Trans mucosal Drug Delivery, Blood Brain Barrier, Optimization of pharmaceutical products, Sustained Drug Delivery Systems, are an uniquely architectured session which plays an important role in the fields of pharmaceutical formulation development and Pharmacology.

Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM),  The Pharmaceutical and Healthcare Sciences Society (PHSS).    

Track 3: Routes of Drug Administration

Aimed and specially designed session for young and senior researcher from academic on drug dosage formulations through novel routes in drug delivery where researcher interested for developing novel routes to minimize drug interactions occur through common routes by which a drug is brought into contact with the body. Different dosage forms are manufactures by pharmaceutical companies according to drug designing to maximize bioavailability. Session includes different routes of administration like Topical drug delivery via a large range of classes including but not limited to creams, foams, gels, lotions, and ointments. Pulmonary drug delivery system route is gaining much importance in the present day research field as it enables to target the drug delivery directly to lung both for local and systemic treatment. Nasal drug delivery an alternative route restricted to intravenous administration this area has been widely investigated in recent years by academics. Topics like other novel routes wise Vaginal drug delivery covers self-insertion creams, foams, gels, irrigations and tablets, are known to reside in the vaginal cavity. Oral Drug Delivery routes to reaching different parts of the body via the bloodstream. Injectable formulations intended for administration by injection, infusion or implantation and placental development into the body.

9^th Asian Biologics and Biosimilars Congress, August 20-22, 2018| Tokyo, Japan; International Conference on Pediatric Hospital Medicine, August 29-30, 2018| Boston, USA; 4^th International Conference and Expo on Drug Discovery, Designing & Development, September 06-07, 2018| London, UK; 6^th International Conference and Exhibition on Pharmacognosy, Phytochemistry & Natural Products, September 17-18, 2018|Beijing, China

Track 4: Pharmaceutical Nanotechnology

Pharmaceutical Nanotechnology for Drug Delivery using Nanotechnology session plays major role in the future of pharmaceutical research. In this session, we will go over several of the most important features of nanotechnology, anticancer drug development , pharmocology of cancer drugs, that will impact our lives but we will also talk about what nanotechnology itself will be like in the future and Investigator specifically from cancer therapy. Interestingly pharmaceutical sciences are using nanoparticles to reduce toxicity and side effects of drugs and up to recently did not realize that carrier systems themselves may impose risks to the patient. Nano technology session includes drug delivery using nanotechnology, Pharmaceutical technology, Nanoparticles permeability to BBB, Cancer drug targets, Nanoparticles application, Pancreatic Cancer, Nanoliposome-mediated delivery, MicroRNA therapeutics, recent breakthroughs in nanoparticle design to demonstrate their high potential as multifunctional drug delivery nanocarrier, Carriers for nanotechnology, various nanostructures, magnetic nanoparticles. In this review Polymer Nanotechnology for Drug Delivery, Nano composite materials, to deliver highly efficient therapeutic compounds to patient a future aspect of Nanotechnology has a vast future ahead of it and we are constantly making breakthroughs in this industry every day.  

Applied Pharmaceutical Nanotechnology Society (APN), Controlled Release Society (CRS), The Pharmaceutical and Healthcare Sciences Society (PHSS).

Track 5: Nucleic Acid Based Drug Delivery

Nucleic acids science and technologies experience tremendous progress and changes. The conference will feature prominent experts discussing latest advances in nucleic acids, industrial pharmacy, pharmaceutical design, drug targeting,  anticancer drug development , Nano pharmaceutics,  research and development: TNA for treating cancer and viral diseases in the near future for drug delivery includes novel Rnai-Based Therapy, advances in siRNA delivery, oligonucleotide drug delivery, viral gene therapy and Artificial microRNAs, non-coding RNA (miRNA, piRNA, lncRNA, and lincRNA) this architect session to play an important role in the fields of cancer targeting and pharmaceutical nanotechnology.

11^th International Conference on Pharmacovigilance & Drug Safety, June 21-22, 2018| London, UK; 4^th International Conference on Drug Discovery, Designing and Development, June 27-28, 2018| Vancouver, Canada; 11^th International Conference on Pharmacology and Ethnopharmacology, July 18-19, 2018| Atlanta, USA; International Conference on Pharmaceutical Oncology, July 18-19, 2018| Atlanta, USA; 12^th Global Ethnomedicine and Ethnopharmacology Conference, August 20-21, 2018|Tokyo, Japan

Track 6: Smart Drug Delivery Systems

To maximize knowledge of the current researcher on developing drug delivery via Pharmaceutical formulation, Smart Drug Delivery conference themed quality topics on Drug Targeting, Drug Designing, Drug evaluation, Drug Delivery and Therapeutics, Biodegradable polymers, Dendrimer a versatile polymer in drug delivery are a uniquely architect session to play an important role in the fields of nanotechnology, pharmaceutical and medicinal chemistry. Major drugs driving growth of the overall smart drug delivery market include Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza and Zoladex

Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM),  The Pharmaceutical and Healthcare Sciences Society (PHSS).    

Track 7: Vaccine Based Drug Delivery Technology

Vaccine is multidisciplinary scientific field that is currently undergoing rapid development. An important component of cancer vaccines is the development of novel vaccine strategies, this session includes Laser technology for Vaccine Adjuvants, Challenges and opportunities For Vaccine Delivery, These advances promise to accelerate the development and testing Jet injectors, micro needles, Needle free drug delivery technology, is an innovative technique to deliver drugs into a person's body without piercing their skin.

11^th European Biosimilars Congress, April 26-27, 2018| Rome, Italy; 15^th Annual European Pharma Congress, May 07-09, 2018| Frankfurt, Germany; 5^th International Conference on Pain Management and Pain Medicine, May 21-22, 2018 | New York, USA; International Conference on Pharmaceutical Research and Development, June 06-07, 2018 | Baltimore, USA; 8^th International Conference on cGMP, GCP & Regulatory Affairs, June 08-09, 2018| Baltimore, USA

Track 8: Drug Delivery Companies and Markets

Drug Delivery  Companies and Market session is beginning to change for small, medium, and large scale pharmaceutical Co, biopharmaceutical Manufacturing and Industries ,  generic drugs companies, contract drug delivery companies which can manifest from development to manufacturing. Addressing these instabilities is a great challenge, because of the complexity of the Clinical bio therapeutics themselves. This session includes Rheological behavior, Pharmaceutical Guidelines, Pharmaceutical companies and regulatory guidelines perspectives, Advances in computational modeling for bioavailability, drug Stability of Pharmaceutical products which are driving crucial research into new vaccines and medicines. The pharmaceutical industry and the public sector are thinking differently than before about how to improve access to medicines and advance research and development for neglected diseases.

Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM),  The Pharmaceutical and Healthcare Sciences Society (PHSS). 

Track 9: Bio therapeutics as Novel Technique in Drug Delivery

As new product formats progress through development and into the regulatory process, the role of Bio therapeutics as Novel Technique in Drug Delivery is important scope. The demand for Biopharmaceuticals manufacturing and industry is continuously increasing, because many Therapeutic Agents are reaching later stage clinical trials. Most bio therapeutic drugs are recombinant monoclonal antibodies which are widely produced in mammalian cell lines because of the need for post-translational modifications that should be alike or at least similar to those obtained in humans. Thus, there is an increase in the market for cell line development. Moreover, advancements in upstream processing technologies have led to improvement in speed and efficiency of generating robust and highly productive cell line for large scale production of protein therapeutics and has propelled the market for cell line development. Major drugs driving growth of the overall smart drug delivery market include Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza,  Zoladex, Beckton Dickinson & Company (U.S.), Beckman Coulter (U.S.), Boehringer Ingelheim Group (Germany), Catalent Inc. (U.S.), CMC Biologics A/S (Denmark), Lonza Group Ltd. (Switzerland), EMD Millipore (U.S.), Partec (Sysmex Corporation) (Japan), ProBioGen AG (Germany), Selexis SA (Germany), Sigma-Aldrich Co. LLC.

According to a New Market Research “Bio therapeutics as Novel Technique in Drug Delivery   Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2022”, the Bio therapeutics as Novel Technique in Drug Delivery was valued at US$56.03 mn in 2015 and is anticipated to expand at a CAGR of 7.5% from 2015 to 2022 to reach US$99.84 mn by 2022.

12^th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry, February 26- 27, 2018| London, UK; 16^th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, March 19-21, 2018|Berlin, Germany; 5^th Annual Congress on Chemistry in Drug Discovery & Designing, April 16-17, 2018| Dubai , UAE; International Conference on Nano Medicine and Nanoparticles, April 18-19, 2018| Las Vegas, USA; 4^th International Conference on Antibiotics: R&D, B2B, April 20-21, 2018| Las Vegas, USA;

Track 10: Drug Delivery and Device Development

In this session we will focus on Medical Devices designed for drug delivery through the pulmonary and nasal routes. These routes are of interest for local delivery, as in asthma, but also for rapid delivery of drugs to the system circulation and direct delivery to the central nervous system. Devices that account for specific anatomical and physiological features of the intranasal and pulmonary routes will be featured.  Drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a specific route of administration. Such devices are used as part of one or more medical treatments. Many in the industry have long felt overly burdened by what they consider to be an unnecessarily complex approval process. Critics claim it impedes innovation and delays the availability of better health care. To change that perception, the FDA last year announced $40 million to a new Medical Device Innovation Consortium (MDIC) charged with simplifying the process of designing and testing new technologies. With input from industry, government, and other nonprofit organizations, public-private MDIC will prioritize the regulatory science needs of the medical device community and fund projects to streamline the process.

Current research on femtosecond laser microfabrication of fluidic devices is introduced to present their research to elaborate. The research on microfluidics provides highly sensitive microfluidic sensors for practical applications with significant advantages of portability, efficiency, sensitivity, versatility, and low cost.

Congress on Innovation in Drug Delivery (APGI ), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM),  The Pharmaceutical and Healthcare Sciences Society (PHSS).    

Track 11: Recent Advances in Drug Delivery

The scope of this session on research in Recent Advances in Drug Delivery includes

Opportunities and challenges for Drug Delivery Market in the Pharmaceutical analytical Market to forecasts for Drug Delivery Market in the global Pharmaceutical companies from 2009 to 2025. Sessions includes solid pharmaceutical Drug Dosage Formulations, drug bioavailability, Tumor targeting, Tumour Biomarkers, coating materials. The key geographies including the US, Europe, Japan and Emerging Hotspots such as India, Singapore and ChinaTechnology trends in Drug Delivery Market that shape the industryQualitative analysis of the market drivers, barriers, future outlook and challenges for the Drug Delivery Market Analysis of competitive landscape and the leading market players.

11^th European Biosimilars Congress, April 26-27, 2018| Rome, Italy; 15^th Annual European Pharma Congress, May 07-09, 2018| Frankfurt, Germany; 5^th International Conference on Pain Management and Pain Medicine, May 21-22, 2018 | New York, USA; International Conference on Pharmaceutical Research and Development, June 06-07, 2018 | Baltimore, USA; 8^th International Conference on cGMP, GCP & Regulatory Affairs, June 08-09, 2018| Baltimore, USA

Track 12: Major challenges in Drug Delivery

By focusing on Major challenges in Drug Delivery in the drug-delivery technology market

Session includes: Reducing Patient Compliance, Drug Delivery of poorly soluble drugs, Overcoming challenges in pediatric drug delivery, controlling the addictive nature of drugs, Polymeric enhancement.

There is an increasing demand for effective and, ideally, non-invasive drug-delivery methods. This is especially the case for the biopharmaceutical sector, which has experienced an overwhelming growth due to advances in biotechnology. In 2009, over $12 billion were invested in biologics / biotechnology research and development (R&D), representing a 26% share in the total R&D expenditure. A recent report by the Pharmaceutical Research and Manufacturers of America (PhRMA) states that in 2015 there were 901 biological in development, targeting more than 100 diseases.

Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM),  The Pharmaceutical and Healthcare Sciences Society (PHSS).    

 Track 13:  Peptide and Protein Drug Delivery

This session and track is intended to assist pharmaceutical scientists in the development of stable Medicinal Preparations of Proteins and Peptides during the early stages of the product development process for Pharmaceutical technology providing a comprehensive review of mechanisms and causes of protein instability in formulation development, coverage of accelerated stability testing methods and relevant analytical methods, and an overview of the drug substance manufacturing process. Preformulation and the development of traditional solutions and lyophilized formulations frequently used for intravenous delivery and non-traditional formulations are also addressed.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

11^th International Conference on Pharmacovigilance & Drug Safety, June 21-22, 2018| London, UK; 4^th International Conference on Drug Discovery, Designing and Development, June 27-28, 2018| Vancouver, Canada; 11^th International Conference on Pharmacology and Ethnopharmacology, July 18-19, 2018| Atlanta, USA; International Conference on Pharmaceutical Oncology, July 18-19, 2018| Atlanta, USA; 12^th Global Ethnomedicine and Ethnopharmacology Conference, August 20-21, 2018|Tokyo, Japan

Track 14:  Drug Delivery Equipment and Machinery

Equipment and Machinery for Drug Delivery session includes major area participants/ Vendors, Engineers in Equipments from Laboratory equipments, Analytical Equipments, Auto Injectors, Semi-Automatic R&D Equipment, Large volume Production Machineries and Drug Delivery Pilot Equipments.

Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM),  The Pharmaceutical and Healthcare Sciences Society (PHSS).      

 Track 15: Business Opportunities in Drug Delivery

The global market for Business Development of Drug Delivery Technology in 2010 was $131.6 billion and is expected to rise at a compound annual growth rate (CAGR) of 5% and reach nearly $175.6 billion by 2016. The U.S. constituted approximately 59% of the total drug delivery market in 2010 and was $78 billion. It is forecast to reach nearly $103 billion in 2016 at a CAGR of 4.7%. Europe contributed about 27% of the total drug delivery market in 2010 and was $36 billion and is expected to grow to $49 billion by 2016 at a CAGR of 5.6% for 2013, Drug Delivery Global market reached $150.3 billion, according to BCC research. This was an increase from $142 billion the previous year. Given its predicted annual growth the market represents a considerable business opportunity, which has been reflected in the increasing number of drug delivery specialists. Consistent quality and competitive costs of product improves Production performance and continuity of supply and Product and technology auditing and due diligence with minimizing Regulatory Issues, quality control, and business development Business opportunities in drug delivery.

9^th Asian Biologics and Biosimilars Congress, August 20-22, 2018| Tokyo, Japan; International Conference on Pediatric Hospital Medicine, August 29-30, 2018| Boston, USA; 4^th International Conference and Expo on Drug Discovery, Designing & Development, September 06-07, 2018| London, UK; 6^th International Conference and Exhibition on Pharmacognosy, Phytochemistry & Natural Products, September 17-18, 2018|Beijing, China;

Societies and Assosiation

Congress on Innovation in Drug Delivery (APGI), Controlled Release Society (CRS), International Society for Aerosols in Medicine (ISAM),  The Pharmaceutical and Healthcare Sciences Society (PHSS). 

Summary of Drug Delivery 2018 Conference:

Drug Delivery 2018 passes on late advancements in Novel Drug Delivery Systems (NDDS), approaches in tranquilize conveyance frameworks and Challenges

Transporter intervened medicate conveyance has developed as an effective technique for the treatment of different pathologies. The helpful file of conventional and novel Drugs is improved by means of the expansion of specificity because of focusing of Drugs to a specific tissue, cell or intracellular compartment, the control over discharge energy, the security of the dynamic operator or a blend of the above. Nanoparticles (NPs) were proposed as Drug transporters more than 30 years back and have gotten developing consideration since, principally because of their solidness, improved stacking abilities and control over physicochemical properties. The one of a kind pathophysiology of strong tumors permits inactive amassing of NPs at these locales upon intravenous infusion. Moreover, stealth NPs with long flow times is more proficient in achieving tumor tissue.

The worldwide propelled medicate conveyance market ought to develop from generally $178.8 billion of every 2016 to almost $227.3 billion by 2021, with a compound yearly development rate (CAGR) of 4.9%.

Significance and Scope:

Medication conveyance alludes to approaches, definitions, advances, and frameworks for transporting a pharmaceutical compound in the body as expected to securely accomplish its coveted restorative impact. This meeting will examine powerful detailing and conveyance advancements for upgrading solvency and medication conveyance. Medication conveyance 2016 expects to total driving specialists from around the globe who will talk about on detailing and conveyance, and show how they are forming ineffectively solvent medications into experimentally stable, understanding driven definitions, and diminishing their item improvement courses of events. It additionally gives the opportunity to analysts, professionals and teachers to display and examine the latest advancements, patterns, and concerns, handy difficulties experienced and the arrangements received in the fields of Drug conveyance.

Medication conveyance 2018 will feature new and inventive advances by prestigious researchers. It advantages to pharmacological, specialists, teachers, and organizations. Gatherings likewise advantages and offer information between researcher, specialists and representatives. Trade of thought among organizations and they share information to each other about their item at the gathering prompting lead to Public-private associations and joint efforts. The college part go to gatherings to know and offer about what investigate has just been done and what examine will be done in the territory of medication conveyance. We unite business, innovative, and innovation pioneers from the Drug Deliver industry for the most present and significant.

Look at Market of Drug Delivery:

The worldwide propelled sedate conveyance market ought to develop from generally $178.8 billion of every 2016 to almost $227.3 billion by 2020, with a compound yearly development rate (CAGR) of 4.9%. Examinations of worldwide market patterns, with information from 2014, gauges for 2016, and projections of compound yearly development rates (CAGRs) to 2020

For 2016, Drug Delivery Global market came to $150.3 billion, as indicated by BCC explore. This was an expansion from $142 billion the earlier year. Given its anticipated yearly development the market speaks to an impressive business opportunity, which has been reflected in the expanding number of medication conveyance experts. 

 Figure 1: Drug Delivery Market worldwide (2013-15)

Figure 2: Worldwide Market (2015-2020)

Major Drug Delivery Associations around the Globe

• Controlled Release Society
• Society for biomaterials
• Washington State Pharmacy Association
• Inhalation Drug Delivery Association
• International society of drug delivery sciences and technology.
• American Association of Pharmaceutical Scientists
• Japanese Society of Drug Delivery Systems
• Parenteral Drug Association
• International Association for Pharmaceutical Technology

Top Universities in USA

• Harvard University
• Stanford University
• University California
• Massachusetts Inst Tech (MIT)
• California Inst Tech
• Princeton University
• University Chicago
• Yale University
• Cornell University
• University Pennsylvania

Global

• University Oxford
• Tokyo University
• Kyoto University
• Imperial College London
• University British Columbia
• Tech University Munich
• University Paris 11
• University Zurich

Top companies playing key roles in drug delivery

USA

• Oncolytics Biotech
• Bristol-Myers Squibb
• GlaxoSmithKline
• Bend Research
• Pfizer
• Bio Delivery Sciences